Ana Santaballa

1.7k total citations
87 papers, 753 citations indexed

About

Ana Santaballa is a scholar working on Oncology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Ana Santaballa has authored 87 papers receiving a total of 753 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Oncology, 32 papers in Reproductive Medicine and 20 papers in Cancer Research. Recurrent topics in Ana Santaballa's work include Ovarian cancer diagnosis and treatment (30 papers), PARP inhibition in cancer therapy (14 papers) and Breast Cancer Treatment Studies (13 papers). Ana Santaballa is often cited by papers focused on Ovarian cancer diagnosis and treatment (30 papers), PARP inhibition in cancer therapy (14 papers) and Breast Cancer Treatment Studies (13 papers). Ana Santaballa collaborates with scholars based in Spain, United States and Italy. Ana Santaballa's co-authors include Joaquín Montalar, Laura Palomar, B. Munárriz, Antonio González-Martı́n, Yolanda García García, María A. Pastor, Blanca Munárriz, Andrés Redondo, A. Oltra and Carmen Beato and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Ana Santaballa

77 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Santaballa Spain 17 337 197 194 180 138 87 753
George Zarkavelis Greece 15 458 1.4× 158 0.8× 130 0.7× 169 0.9× 170 1.2× 52 813
Loredana Miglietta Italy 17 296 0.9× 137 0.7× 115 0.6× 145 0.8× 116 0.8× 48 605
Ingrid Boere Netherlands 19 555 1.6× 120 0.6× 210 1.1× 186 1.0× 194 1.4× 72 1.0k
Charlotte Vaysse France 16 293 0.9× 162 0.8× 221 1.1× 188 1.0× 75 0.5× 66 985
Robert D. Legare United States 14 449 1.3× 230 1.2× 90 0.5× 150 0.8× 68 0.5× 35 822
Sally Baron‐Hay Australia 14 388 1.2× 113 0.6× 220 1.1× 237 1.3× 70 0.5× 48 775
Florence Coussy France 15 393 1.2× 295 1.5× 61 0.3× 185 1.0× 139 1.0× 59 734
Tjoung‐Won Park‐Simon Germany 15 325 1.0× 93 0.5× 137 0.7× 208 1.2× 126 0.9× 46 629
Wulf Siggelkow Germany 13 193 0.6× 168 0.9× 112 0.6× 129 0.7× 84 0.6× 31 809
Aliki Taylor United Kingdom 11 385 1.1× 112 0.6× 93 0.5× 133 0.7× 87 0.6× 17 613

Countries citing papers authored by Ana Santaballa

Since Specialization
Citations

This map shows the geographic impact of Ana Santaballa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Santaballa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Santaballa more than expected).

Fields of papers citing papers by Ana Santaballa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Santaballa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Santaballa. The network helps show where Ana Santaballa may publish in the future.

Co-authorship network of co-authors of Ana Santaballa

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Santaballa. A scholar is included among the top collaborators of Ana Santaballa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Santaballa. Ana Santaballa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Higuera, Oliver, et al.. (2025). Sex and gender differences in cancer pathogenesis and pharmacology. Clinical & Translational Oncology. 27(10). 3837–3848. 4 indexed citations
2.
Santaballa, Ana, et al.. (2025). Sex-related differences in the efficacy and toxicity of cancer treatments. Clinical & Translational Oncology. 27(9). 3636–3646. 1 indexed citations
3.
4.
García-Donás, Jesús, Andrés Redondo, Ana Santaballa, et al.. (2024). Phase II clinical trial assessing the efficacy of enzalutamide in advanced non-resectable granulosa cell ovarian tumors: The GREKO III study (GETHI2016–01). Gynecologic Oncology. 191. 233–239.
5.
Guerrero, Ángel, Miguel Gil‐Gil, Christoph Zielinski, et al.. (2023). Cyclin E cytoplasmatic isoform to predict outcome and benefit to capecitabine treatment in patients with HR+/HER2- metastatic breast cancer from the GEICAM/2013-02 PEARL study.. Journal of Clinical Oncology. 41(16_suppl). 1023–1023. 1 indexed citations
6.
Tavira, Beatriz, Luís Manso, Ana Santaballa, et al.. (2023). Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study). Clinical Cancer Research. 30(1). 176–186. 6 indexed citations
7.
Fiol, Gabriel, Iñaki Lete, Laura Nieto, et al.. (2023). Associations between Menopausal Hormone Therapy and Colorectal, Lung, or Melanoma Cancer Recurrence and Mortality: A Narrative Review. Journal of Clinical Medicine. 12(16). 5263–5263. 1 indexed citations
8.
Santisteban, Marta, Josep Lupón, José Manuel Aramendía, et al.. (2022). A Fibrosis Biomarker Early Predicts Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy. Cancers. 14(12). 2941–2941. 4 indexed citations
9.
Barretina-Ginesta, Maria-Pilar, María Quindós, Lydia Gaba, et al.. (2022). SEOM-GEICO clinical guidelines on endometrial cancer (2021). Clinical & Translational Oncology. 24(4). 625–634. 12 indexed citations
10.
Santaballa, Ana, Catalina Márquez-Vega, Álvaro Rodríguez-Lescure, et al.. (2021). Multidisciplinary consensus on the criteria for fertility preservation in cancer patients. Clinical & Translational Oncology. 24(2). 227–243. 28 indexed citations
11.
Elez, Élena, Francisco Ayala, Enriqueta Felip, et al.. (2021). Gender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM). ESMO Open. 6(2). 100048–100048. 9 indexed citations
12.
Santaballa, Ana, et al.. (2020). SEOM clinical guideline for secondary prevention (2019). Clinical & Translational Oncology. 22(2). 187–192. 6 indexed citations
13.
Santaballa, Ana, et al.. (2017). SEOM clinical guidelines for endometrial cancer (2017). Clinical & Translational Oncology. 20(1). 29–37. 21 indexed citations
14.
Santaballa, Ana, Yolanda García García, Ana Herrero, et al.. (2017). SEOM clinical guidelines in gestational trophoblastic disease (2017). Clinical & Translational Oncology. 20(1). 38–46. 28 indexed citations
15.
Coloma, Carmen Salvador, Pilar Sepúlveda, Laura Palomar, et al.. (2016). Anthracycline mediated cardiotoxicity: Detection of miRNA based early biomarkers for the prediction of myocardial injury. Hecatos study. Annals of Oncology. 27. vi90–vi90.
16.
Bruixola, G., Santiago Domingo, Roberto Díaz, et al.. (2014). Feasibility and Safety of a Modified Outpatient Regimen With Intravenous/Intraperitoneal Chemotherapy for Optimally Debulked Stage III Ovarian Cancer. International Journal of Gynecological Cancer. 25(2). 214–221. 3 indexed citations
17.
18.
Santaballa, Ana, et al.. (2009). Mujeres con cáncer de mama: evaluación del afecto positivo y negativo y valoración de un programa de Intervención psicológica en el ámbito hospitalario. SHILAP Revista de lepidopterología. 4 indexed citations
19.
Fidalgo, José Alejandro Pérez, Isabel Chirivella, Josefa Ibáñez, et al.. (2008). Impact of mammography screening programme in the breast cancer population of the Region of Valencia (Spain). Clinical & Translational Oncology. 10(11). 745–752. 7 indexed citations
20.
Segura, Ángel, et al.. (2000). Cisplatin Plus Vinorelbine for Patients with Advanced Head and Neck Squamous Cell Carcinoma. The Oncologist. 5(2). 177–178. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by George Zarkavelis Breakdown of academic impact, for papers by Loredana Miglietta Breakdown of academic impact, for papers by Ingrid Boere Breakdown of academic impact, for papers by Charlotte Vaysse Breakdown of academic impact, for papers by Robert D. Legare Breakdown of academic impact, for papers by Sally Baron‐Hay Breakdown of academic impact, for papers by Florence Coussy Breakdown of academic impact, for papers by Tjoung‐Won Park‐Simon Breakdown of academic impact, for papers by Wulf Siggelkow Breakdown of academic impact, for papers by Aliki Taylor
Rankless by CCL
2026